Brief: Chinook Therapeutics Inc Reports Q3 EPS Of $0.83
10/11/2022 21:03
Nov 10 (Reuters) - Chinook Therapeutics Inc KDNY.O :
* CHINOOK THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
THIRD
QUARTER 2022 FINANCIAL RESULTS
* CHINOOK THERAPEUTICS INC - QTRLY EPS $0.83
Source text for Eikon: ID:nGNX3YmhVK
Further company coverage: KDNY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chinook Therapeutics
See all newsBrief: Novartis Completes Acquisition Of Chinook Therapeutics
Chinook Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Chinook Therapeutics Inc expected to post a loss of 81 cents a share - Earnings Preview
Brief: Chinook Therapeutics Announces First Patient Enrolled In Phase 3 Of Zigakibart
Brief: Muddy Waters- Remains Short On Chinook Therapeutics Inc